Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $2.38 million. The enterprise value is -$1.20 million.
Important Dates
The next estimated earnings date is Wednesday, January 21, 2026, after market close.
| Earnings Date | Jan 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 20.66 million shares outstanding. The number of shares has increased by 117.96% in one year.
| Current Share Class | 20.66M |
| Shares Outstanding | 20.66M |
| Shares Change (YoY) | +117.96% |
| Shares Change (QoQ) | +6.09% |
| Owned by Insiders (%) | 16.72% |
| Owned by Institutions (%) | 1.36% |
| Float | 17.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.65 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.32 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -183.70 |
Financial Efficiency
Return on equity (ROE) is -178.64% and return on invested capital (ROIC) is -156.58%.
| Return on Equity (ROE) | -178.64% |
| Return on Assets (ROA) | -59.68% |
| Return on Invested Capital (ROIC) | -156.58% |
| Return on Capital Employed (ROCE) | -543.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $165,371 in taxes.
| Income Tax | 165,371 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.93% in the last 52 weeks. The beta is -1.24, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.24 |
| 52-Week Price Change | -90.93% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 13.61 |
| Average Volume (20 Days) | 36,676,455 |
Short Selling Information
The latest short interest is 2.85 million, so 13.79% of the outstanding shares have been sold short.
| Short Interest | 2.85M |
| Short Previous Month | 257,653 |
| Short % of Shares Out | 13.79% |
| Short % of Float | 16.56% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.80M |
| Pretax Income | -3.89M |
| Net Income | -4.05M |
| EBITDA | -5.79M |
| EBIT | -5.80M |
| Earnings Per Share (EPS) | -$0.86 |
Full Income StatementBalance Sheet
The company has $3.50 million in cash and $28,439 in debt, giving a net cash position of $3.47 million or $0.17 per share.
| Cash & Cash Equivalents | 3.50M |
| Total Debt | 28,439 |
| Net Cash | 3.47M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 1.07M |
| Book Value Per Share | 0.20 |
| Working Capital | 918,215 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.53M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
